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Abstract Establishing an effective three-dimensional (3D) in vitro culture system to better model human
neurological diseases is desirable, since the human brain is a 3D structure. Here, we demonstrated the
development of a polydimethylsiloxane (PDMS) pillar-based 3D scaffold that mimicked the 3D
microenvironment of the brain. We utilized this scaffold for the growth of human cortical glutamatergic
neurons that were differentiated from human pluripotent stem cells. In comparison with the 2D culture, we
demonstrated that the developed 3D culture promoted the maturation of human cortical glutamatergic
neurons by showing signiﬁcantly more MAP2 and less Ki67 expression. Based on this 3D culture system,
we further developed an in vitro disease-like model of traumatic brain injury (TBI), which showed a
robust increase of glutamate-release from the neurons, in response to mechanical impacts, recapitulating
the critical pathology of TBI. The increased glutamate-release from our 3D culture model was attenuated
by the treatment of neural protective drugs, memantine or nimodipine. The established 3D in vitro human
neural culture system and TBI-like model may be used to facilitate mechanistic studies and drug screening
for neurotrauma or other neurological diseases.
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1.

Introduction

The human cerebral cortex is the most complicated organ that plays
essential roles in learning and memory, emotion, cognitive and motor
function1–3. Damage or degeneration of the human cerebral cortex
causes severe diseases, for example, traumatic brain injury (TBI)related cognitive defects. However, the human brain disease model
for studying the pathogenesis and treatment is absent. The recent
breakthroughs in the study of human pluripotent stem cells (hESC,
human embryonic stem cell; iPSC, induced pluripotent stem cells)4–6,
have provided powerful tools to generate all types of human cells7–9,
including human cortical neurons of the cerebral cortex10–13. However, the classic generation and maturation of hPSC-derived cortical
neurons on 2D planar coverslip do not accurately mimic the human
neural micro-environment. As a result, some essential characteristics
of the hPSC-derived cortical neurons are altered in the 2D culture,
and the in vitro observation is often inconsistent with the in vivo14.
This drawback leads to challenges in the etiology study that is based
on hPSC-derived cortical neurons, such as TBI. Therefore, recreating
in vivo physiological characteristics of hPSC-derived cortical neurons
is imperative.
The 3D structure provides a better cell growth microenvironment than the 2D planar coverslip. The mRNA levels of
functional genes in neuronal adhesion, regenerative growth, and
synaptogenesis were much higher in the 3D structure, in comparison with the 2D culture15, suggesting that the scaffold's architecture may improve the cell binding and neuronal outgrowth.
Indeed, the capacity of cell adhesion and the formation of a
functional structure are enhanced in the 3D culture16. However,
there remain unsolved concerns regarding the 3D culture: (1) culturing human-speciﬁc neural lineage, for example, human cortical
glutamatergic neurons15,17, is lacking; (2) 3D cultures for modeling human neurological diseases like TBI have not been well
established17–19; (3) drug studies for neurological diseases by
using 3D culture have not yet been reported15,19.
Herein, we designed the hPSC-derived human cortical neurons
with the brain-like function on a polydimethylsiloxane (PDMS)
micropillar surface. Adapted with the structure of these 3D micropillars, the differentiation of human cortical neurons was promoted,
and the proliferation of neural progenitors was inhibited, which
subsequently resulted in the maturation of a glutamatergic neuron-rich
culture system. Furthermore, the mimicking of brain injury and drug
tests were attempted on the 3D culture system.

2.
2.1.

Materials and methods
Construction of PDMS pillars

The scaffold was produced by a one-step casting replication
process as previously reported20. The area of the pattern region
was 1 cm  1 cm. The mold was salinized overnight with
(tridecaﬂuoro-1,1,2,2-tetrahydrooctyl)-1-trichlorosilane. The 10:1
mixture of the PDMS base and the curing reagent was spread over

the salinized silicon mold, and cured at 100 1C for 5 min. After
curing, the PDMS layer was broken off from the mold in an
isopropanol medium. Then, the PDMS layer was stored in 75%
ethanol. After a 24–48 h soaking, the PDMS scaffold was moved
to a cell-culture hood and washed with phosphate-buffered saline
for 3 times. Before the cells were seeded into the 3D PDMS
scaffold, the device was coated with Matrigel (Discovery Labware,
Inc., Bedford, USA) for overnight.
2.2.

hPSCs maintenance and passage

Human ESCs (H9, passages 60–80, WiCell Agreement No. 16W0060) and human iPSCs (IMR90-4, passage 40–50, WiCell
Agreement No. 17-W0063) were maintained in a feeder-free
environment on vitronectin (Life Technologies, Maryland,
USA)-coated plates21,22. A standard protocol using Essential
8 basal medium (Life Technologies, Carlsbad, CA, USA) was
previously reported on http://www.wicell.org. hPSC colonies were
passaged by using EDTA (Lonza Inc., MA, USA) when they
became 70% conﬂuent.
2.3. Differentiation of cortical glutamatergic neurons from
hPSCs
To start the differentiation, hPSCs colonies were treated with
1 U/mL dispase (Life Technologies, MA, USA) at 37 1C for
1–2 min as previously reported13. After detachment, the cells were
suspended in neural induction medium (NIM). The colonies were
aggregated to shape embryonic bodies (EBs) from day 0 to day 7.
At day 7, the EBs were attached to 6-well plates for neural rosette
formation. The rosette structure was observed at day 10. At day
16, the rosettes were detached by a 1000 μL pipette and resuspended in NIM containing B27 (Life Technologies, New York,
USA), which may reduce the damage caused by the mechanical
pipette. At day 17, the cells formed neural spheres (NSs). At day
24, NS were dissociated with TrypLE (Life Technologies, CA,
USA) and seeded onto a coverslip pre-coated with Matrigel at a
density of 40,000 cells per coverslip in 12-well plates. After 2 h,
1.5 mL pre-warmed NIM containing B27 was added into each
well. Moreover, NSs were also dissociated into 3D scaffolds precoated with Matrigel at a density of 35,000 cells/cm2 in 6-well
plates. After 2 h, 1.5 mL pre-warmed NIM containing B27 was
added into each well. The medium was refreshed every 7 days.
2.4.

Quantitative real-time polymerase chain reaction (qPCR)

Cells were collected at day 28 and dissociated with Trizol reagent.
The RNA was extracted from neurons and diluted to 1 μg with
DEPC-treated water. SuperScript III First-Strand system (Life
Technologies, CA, USA) was used to synthesize the cDNA. qPCR
analysis was performed in the 20 μL reaction system, which
consisted of 4 μL cDNA, 2 μL random primers, 2 μL ddH2O and
10 μL 2X SYBR Green RCR Master Mix (Roche Molecular
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Systems, Inc. Basel, Switzerland). Glyceraldehyde-3-phosphate
dehydrogenase was used as a housekeeping gene. Primers were
listed in Supporting Information Table S1.

3
3 h, and memantine was added 10 h before the blunt hit. Solution
samples were collected (150 μL) before and after injury for analysis.
2.8.

2.5.

Cells were ﬁxed with 4% paraformaldehyde (PFA) for 30 min at 4 1C.
Then the cells were washed with phosphate-buffered saline (PBS) for
5 min. After being washed with PBS for 3 times, the cells were
processed with 0.2% Triton X-100 for 10 min and then 10% donkey
serum for 1 h at room temperature. The cells were incubated with
primary antibodies, which were in 0.1% Triton X-100 and 5% donkey
serum at 4 1C for overnight. On the next day, the cells were washed
with PBS for 10 min. After being washed with PBS 3 times, secondary
antibodies were prepared in 5% donkey serum. Moreover, the samples
were incubated for 30 min at room temperature, avoiding light during
the whole process. The nuclei were counterstained with Hoechst 33258
(Molecular Probes, Inc, Oregon, USA). Then, the cells were washed
with PBS for 3 times 10 min, and mounted for ﬂuorescent imaging.
Cell death was detected using TUNEL assay (Vazyme biotech co.,
Ltd., Nanjing, China), following the manufacturer's protocol. Antibodies are listed in Supporting Information Table S2.
2.6.

Glutamate concentration measurement

Approximately 50 μL of collected D45 neuron medium was added
to the 100 μL reagent. After incubation at 37 1C for 30 min, the
sample was added to 96-well plates (50 μL/well). The glutamate
concentration was detected by using a microplate reader (Molecular Devices Spectra Max M2, Molecular Devices, CA, USA).
Reagents were obtained from Sigma Technology. The stocking
concentration of nimodipine and memantine was 10 mmol/L in
DMSO. These two compound solutions were stored in 80 1C,
and the working concentration of nimodipine and memantine was
100 nmol/L. Nimodipine was added 3 h ahead of injury, and
memantine was added 10 h ahead of injury.
2.7.

Statistical analysis

Immunocytochemistry

Establishment of brain injury-like model

A custom-made weight-drop setup (a 7.5 g weight and a 15 mL tube
for the height) was used for inducing injury. Nimodipine was added

To quantify the results, a ﬂuorescence microscope (Nikon Microscope ECLIPSE 80i, New York, USA) was used to capture the
images. At least 12 random ﬁelds were chosen, and more than
5000 cells of each cell line were quantiﬁed, and at least
3 independent differentiation assays were performed. The images
were constructed using Adobe Illustrator CC. Values were
obtained using paired t-test with Image-J software(National
Institutes of Health, MA, USA). The data are presented as SEM,
and P-valueo 0.05 was considered signiﬁcant.
3.

Results

3.1. 3D PDMS pillars promoted the differentiation of hPSCderived neurons
An array of PDMS pillars were designed to perform the neural
growth and differentiation. Human embryonic stem cell (hESC)derived neural progenitors (H9) at differentiated day 24 (D24) were
dissociated by TrypLE, and seeded on Matrigel-coated 3D PDMS
with these soft pillars (Fig. 1A–B). For comparison, the cells were
cultured on 2D coverslip and 2D (planar) PDMS surface as “2D
PDMS group”. At day 28 (D28), the expressions of NESTIN, the
marker of neural stem cells, and KI67, the marker of dividing cells,
were decreased in the 3D PDMS group. Moreover, the expressions of
DCX, the marker of newly born neurons, and TUJ1, the marker of
neurons, were increased in the 3D PDMS group (Fig. 2A–C). qPCR
analysis of cortical neurons (TBR1 and CTIP2) and mature neurons
(NEUN and MAP2) indicated that 3D PDMS pillars promoted the
differentiation and maturation of cortical neurons (Fig. 2D). To
exclude the possible discrepancy of the dorsal forebrain identity on
these two surfaces, the cells were labeled with PAX6, the marker of
cortical progenitor cell, and FOXG1, the marker of forebrain
progenitor cell (Fig. 2E). Similar percentages of PAX6 and FOXG1
were obtained, which indicated that the 3D PDMS surface did not
change the cell fate of dorsal forebrain. These results suggested that
the 3D PDMS structure inhibited the cell proliferation and promoted

Figure 1 Schematic illustration of the PDMS-based 3D culture system and the timeline of cell culture. (A) The 3D PDMS pillar-based scaffold
was produced by a one-step casting replication process. (B) Human pluripotent stem cells were differentiated into cortical progenitor cells by a
timeline, and then seeded on different materials.
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Figure 2 3D culture promoted the differentiation of hPSC-derived neurons. (A) Immunocytochemistry of dividing marker KI67 and neuronal marker
TUJ-1 at D28. Scale bar, 50 μm. (B) Immunocytochemistry of neural stem cell marker NESTIN and newborn neurons marker DCX at D28. Scar bar,
50 μm. (C) Proportion of KI67, TUJ-1, NESTIN, and DCX in total cells at D28. *Po 0.05; **Po 0.01; ***Po 0.001. (D) PCR analysis of hPSC-derived
neurons at D28. (E) Immunocytochemistry of proliferative cells-related marker PAX6 and forebrain neurons-related marker FOXG1 under 2D and 3D
conditions at D28. Scar bar, 50 μm. (F) Immunocytochemistry of division cells-related marker KI67 and mature neurons related marker MAP2 under 2D
coverslip and 3D PDMS conditions at D28 and D35. Two independent cell lines, H9 and IMR90-4, were used to perform the experiments. Scar bar,
50 μm. (G) Proportion of KI67þ and MAP2þ cells in total cells at D28 and D35. *Po 0.05; **Po 0.01; ***Po 0.001. The data are presented as the
mean7SEM, nZ 3 in each condition. More than 1500 cells from random ﬁelds were manually counted in each condition.

the neural differentiation that derived from hPSCs. One additional cell
line, induced pluripotent stem cell line (IMR 90-4), was used to test
the effect of the 3D culture environment on neural proliferation and
maturation (Fig. 2F). Similar results were observed between H9
hESC and IMR90-4 hiPSC-derived neurons on the 3D culture. At
day 35 (D35), the expression of KI67 further decreased, and the
expression of MAP2, the marker of mature neurons, increased in the
3D PDMS group (Fig. 2G).

3.2.

The density of PDMS pillars affects the neural maturation

To further determine whether the density of PDMS pillars affected
human neural differentiation and maturation, we plated the human
cortical progenitors on dense and sparse PDMS surfaces, respectively (Fig. 3A–B). In the dense region, the distance between
pillars is from 3.18 to 6.55 μm. Whereas in the loose region, the
distance between pillars is from 8.14 to 13.7 μm (Fig. 3A–B). At
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Figure 3 The density of PDMS pillars affected the neural maturation. (A) Optical microscopic images (top view) of dense and sparse regions
(upper: scale bar ¼ 200 μm; lower: scale bar ¼ 50 μm). (B) Scanning electron microscopic images (top view) of 3D PDMS pillars. Left two
panels were sparse regions, and right two panels were dense regions. Upper panels were lower magniﬁcant images (left: scale bar ¼150 μm; right:
scale bar ¼ 200 μm), and lower panels were higher magniﬁcant images (scale bar, left ¼ 40 μm, right ¼ 50 μm.) (C) Proportion of KI67þ,
TUJ-1þ, and MAP2þ cells in dense and sparse regions at D35. **Po 0.01; ns, no signiﬁcance. More than 1500 cells from random ﬁelds were
manually counted in each condition. The data are presented as the mean7SEM, n Z 3 in each condition.

day 35 (D35), the proportion of dividing cells, differentiated
neurons and mature neurons were quantiﬁed. The percentage of
KI67 and TUJ1 positive cells among total cells were approximately 25% and 40%, respectively (Fig. 3C). Interestingly, more
MAP2 positive cells were observed on the 3D PDMS surface with
dense pillars (Fig. 3C), suggesting that the possible reason is that
denser pillars may provide more binding sites for neurons, which
in turn creates a more stable microenvironment for neurites growth
to be more mature. Altogether, the 3D PDMS structure promoted
neuronal differentiation of neural progenitor cells and the maturation of neurons. Furthermore, the higher density of PDMS pillars
enhanced the maturation of hPSC-derived neurons.
3.3. 3D PDMS pillars promoted the maturation of hPSC-derived
cortical cells
The generation of cortical neurons is crucial during the development of the human brain. Therefore, we next determined the
generation of cortical neurons in the 3D PDMS group. At day 42
(D42), the expression of TBR1 (the T-box homeobox protein,
localized in SP and CP, and later in layer V) and the superﬁciallayer cortical marker CTIP2 (the transcription factor related to

specifying subcortical projection neurons) were signiﬁcantly
increased in the 3D PDMS group (Fig. 4A). Notably, SATB2,
the marker of cortical neurons in upper layers, was remarkably
expressed in the 3D PDMS group, while it was barely found in the
2D group at day 42 (D42) (Fig. 4A). The results indicated that the
3D PDMS pillars promoted the generation of cortical neurons,
compared to the 2D planar culture (Fig. 4B).
3.4. 3D PDMS pillars promoted the maturation of human
neurons
Since the generation of more mature neurons favored the production
of a more complex neuronal network, the maturation-related marker
of neurons in the 3D PDMS group was tested. At day 42 (D42), the
primary branch was measured. The result showed that the primary
branch was signiﬁcantly increased in the 3D PDMS group (Fig. 4C).
At day 63 (D63), the density of SYNAPTOPHYSINþ puncta
that localized along the neurites was higher in the 3D
PDMS group (Fig. 4D). Signiﬁcantly, an average of
8 SYNAPTOPHYSINþ puncta per 100 mm neurites in the 3D PDMS
group was observed, compared to the 4.5 SYNAPTOPHYSINþ
puncta per 100 mm neurites in the 2D group (Fig. 4D–E), which
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Figure 4 3D PDMS device promoted the maturation of hPSC-derived cortical cells. (A) Immunocytochemistry of cortical neurons related markers
(TBR1, CTIP2, and SATB2) and cell nucleus-related marker HO in 2D coverslip and 3D PDMS group at D42. Scar bar, 50 μm. (B) Proportion of
TBR1þ, CTIP2þ and SATB2þ cells in total cells at D42. *Po 0.05; **Po 0.01; ***Po 0.001. The data are presented as the mean7SEM, nZ 3 in
each condition. (C) Primary branches of neurons in 3D culture were more than those in 2D culture. **Po 0.01 (D) Immunocytochemistry of mature
neurons showing MAP2 and presynaptic puncta SYNAPTOPHYSIN. The length of the dendrites is 100 μm. Scale bar, 20 μm. (E) The number of
SYNAPTOPHYSINþ puncta per 100 μm dendrite is signiﬁcantly higher in the 3D group than in the 2D group. **Po 0.01. The data are presented as
the mean7SEM, nZ 3 in each condition. (F) A 3D confocal image of MAP2 (red) and Hoechst (blue). Scale bar, 100 μm.

suggested that the 3D PDMS pillars promoted the maturation of the
cortical neuronal network. The confocal image of D63 neurons
indicated that a 3D neuronal structure had been formed, instead of the
single layer of cortical neurons (Fig. 4F).

3.5.

Traumatic brain injury-like model and drug testing

Finally, to ﬁnd out whether the human neuron 3D culture could
model human brain disease in vitro, we designed a brain-injury
cell disease model to test the application of the human cortical
neurons in the 3D PDMS culture. To model the brain injury, we
used a blunt object for inducing the cell injury (Fig. 5A). To
test the reliability of the dropping model, we compared the
expression of Caspase3 and TUNEL before and after the
dropping. The result showed that the dropping increased the
expression of Caspase3 and TUNEL, which suggested that the
disease modeling is successful (Fig. 5B). Glutamine levels
were increased dramatically 8 min after the dropping (Fig. 5C),

which was consistent with the in vivo study23, suggesting
that the in vitro culture modeled the glutamine release after
the injury.
Nimodipine is a calcium channel blocker used to protect the
neuronal cells in clinical conditions24. We pretreated the
neurons with 100 nmol/L nimodipine 3 h before stimulation,
and the glutamine level was signiﬁcantly reduced after 8 min
post-dropping, compared to the untreated group (Fig. 5C),
suggesting that the nimodipine may maintain the glutamine
levels to protect neurons during injury. The other US Food and
Drug Administration (FDA)-approved medicine, memantine,
that is an antagonist of the excitatory amino acid receptor25,
was tested on the 3D hPSC-derived neurons. Similarly, the
glutamine levels were reduced signiﬁcantly during cell injury
when pretreated with 100 nmol/L memantine (Fig. 5D). Taken
together, our results suggested that the 3D PDMS culture
system provided a dynamic human neuron model which may
be useful for the drug study of brain-injury-related diseases like
TBI or craniocerebral injury.
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Figure 5 A traumatic brain disease-like model was constructed and drugs were administered to rescue the changes. (A) Schematic of
experimental setup. A weight falls freely from 12 cm above the 3D cultures. (B) Proportion of TUNELþ and Caspase3þ cells in total cells at D40.
**
Po 0.01, ***Po 0.001. The data are presented as the mean7SEM. (C) At D45, Glu release level raises signiﬁcantly after dropping with no drug
treatment. This increase is attenuated with the treatment of nimodipine. **Po 0.01. The data are presented as the mean7SEM, n Z 3 in each
condition. (D) At D63, Glu level release raises signiﬁcantly after dropping with no drug treatment. This increase is attenuated with the treatment of
memantine. *Po 0.05. The data are presented as the mean7SEM, nZ3 in each condition. Glu, glutamate.

4.

Discussion

In this study, we built the PDMS scaffold to model the neural 3D
culture micro-environment. Our results suggested that the 3D
PDMS scaffold promoted the neural differentiation and maturation
of hPSCs. Furthermore, the generation of cortical neurons was also
enhanced in the 3D PDMS group. Chitin-alginate 3D microﬁbrous scaffolds18 and Donut-like 3D material15 were reported as
efﬁcient materials to promote the differentiation and maturation of
rodent neuronal cells. Similarly, our study showed that the 3D
PDMS pillars accelerated the maturation of hPSC-derived cortical
neurons. Further, we used our 3D culture system to test the
physiological response of human cortical neurons, and found it to
be close to that in in vivo brain injury. Therefore, our system
provided a dynamic 3D model to study the human cortical
neurons.
Compared to traditional 3D cultures, PDMS is easy to make and
get autoclaved in the lab, and is biocompatible. PDMS has low
attachment for the cell growth, and it has also been conﬁrmed that
PDMS has no negative effect on the neuronal differentiation. In
this study, we promoted the efﬁciency of neuronal differentiation
and maturation by using 3D PDMS scaffolds. Generation of
human cortical neurons usually took a long time in vitro12,13.
For example, SATB2 is the marker for the upper layer of cortical
neurons, which is expressed relatively late. In the traditional 2D
planar culture, SATB2 was not detected until at least ten weeks
(70 days) of differentiation13. In contrast, we found that the
SATB2 was largely expressed in our 3D culture system as early as

day 42 of differentiation, suggesting that our current culture
system enhanced the generation of human cortical neurons in vitro.
Our 3D human cell culture model is vital for studying many
human CNS diseases, which is inaccessible in 2D cultures26. To
improve the use of 3D scaffolds for drug screening and drug
delivery purposes, it is required to alter the chemical and
biophysical properties of the materials to better suit of the needs
of the cultured cells and native tissues27. Taking traumatic brain
injury (TBI) as an instance, we showed that human cortical
neurons responded to physiologically relevant impact forces. The
3D cell model exhibited increased injury-induced glutamine
release that was consistent with in vivo studies15. Furthermore,
with the treatment of two brain protective medicines, the
glutamine-release was signiﬁcantly reduced after the TBI-like
simulation. Therefore, our 3D culture system provided a dynamic
model for studying human brain injury in vitro.

5.

Conclusions

Taken together, all of the results showed that our 3D PDMS pillarbased cell model enhanced the generation of human cortical
glutamatergic neurons. Furthermore, the feasibility of a 3D PDMS
culture system was successfully tested by the brain protective
medicines, nimodipine and memantine. After an 8 min period of
brain injury-like stimulation, the glutamine-release was signiﬁcantly reduced with the treatment of these two brain protective
medicines. We provided a dynamic model for traumatic brain
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injury treatment testing in vitro, which might be applied to
neurological studies and drug screening.
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